These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Deep brain stimulation in Huntington's disease: assessment of potential targets. Sharma M; Deogaonkar M J Clin Neurosci; 2015 May; 22(5):812-7. PubMed ID: 25698541 [TBL] [Abstract][Full Text] [Related]
7. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR; Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844 [TBL] [Abstract][Full Text] [Related]
8. Drug discovery and development for Huntington's disease - an orphan indication with high medical need. Heitz F; La Rosa S; Gonzalez-Couto E; Gaviraghi G; Terstappen GC IDrugs; 2008 Sep; 11(9):653-60. PubMed ID: 18763216 [TBL] [Abstract][Full Text] [Related]
9. Bilateral stimulation of the globus pallidus internus to treat choreathetosis in Huntington's disease: technical case report. Hebb MO; Garcia R; Gaudet P; Mendez IM Neurosurgery; 2006 Feb; 58(2):E383; discussion E383. PubMed ID: 16462466 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging striatal volumes: a biomarker for clinical trials in Huntington's disease. Aylward EH Mov Disord; 2014 Sep; 29(11):1429-33. PubMed ID: 25164586 [TBL] [Abstract][Full Text] [Related]
15. Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward. Bachoud-Lévi AC; Massart R; Rosser A Stem Cells; 2021 Feb; 39(2):144-155. PubMed ID: 33176057 [TBL] [Abstract][Full Text] [Related]
18. Management and outcome of pallidal deep brain stimulation in severe Huntington's disease. Huys D; Bartsch C; Poppe P; Lenartz D; Huff W; Prütting J; Timmermann L; Klosterkötter J; Maarouf M; Rommel T; Hartmann A; Sturm V; Kuhn J Fortschr Neurol Psychiatr; 2013 Apr; 81(4):202-5. PubMed ID: 23589113 [TBL] [Abstract][Full Text] [Related]
19. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease. Nithianantharajah J; Hannan AJ Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949 [TBL] [Abstract][Full Text] [Related]